Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapy☆
References (26)
- et al.
Control of life-threatening ventricular arrhythmias by amiodarone
Am Heart J
(1981) - et al.
Clinical efficacy of amiodarone as an antiarrhythmic agent
Am J Cardiol
(1976) - et al.
Clinical pharmacology and therapeutic applications of the antiarrhythmic drug, amiodarone
Am Heart J
(1981) - et al.
The effect of amiodarone, a new antianginal drug, on cardiac muscle
Br J Pharmacol
(1970) - et al.
Pharmacology of amiodarone an antianginal drug with new biological profile
Arzneimittelforsch
(1968) - et al.
Effects of amiodarone on thyroid function in patients with ischemic heart disease
Br Heart J
(1975) - et al.
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: A potential method for monitoring chronic drug therapy
Circulation
(1982) - et al.
Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine, and thyrotropin: A drug influencing peripheral metabolism of thyroid hormones
J Clin Invest
(1976) - et al.
Low T3 syndrome in patients chronically treated with an iodine-containing drug, amiodarone
Clin Endocrinol
(1978) - et al.
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration
J Clin Endocrinol Metab
(1981)
Amiodarone: Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation
N Engl J Med
(1981)
Amiodarone kinetics after oral doses
Clin Pharmacol Ther
(1982)
Iodide-induced thyrotoxicosis
Medicine
(1983)
Cited by (110)
Simultaneous determination of amiodarone and its metabolite desethylamiodarone by high-performance liquid chromatography with chemiluminescent detection
2008, Analytica Chimica ActaCitation Excerpt :This metabolite is pharmacologically active and contributes to the antiarrhythmics effects along with the parent compound [6]. The known adverse effects of amiodarone include hypo- and hyperthyroidism, pulmonary fibrosis, as well as cutaneous, neurological and gastrointestinal toxicity [7–9]. Some of these side effects are close-dependent, emphasizing the need to apply the lowest effective dose and to perform conscientious drug monitoring.
Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile
2008, European Journal of PharmacologyNew lipid nanocapsules exhibit sustained release properties for amiodarone
2002, Journal of Controlled ReleaseDetermination of amiodarone and desethylamiodarone in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry with an ion trap detector
2002, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesInterfacial properties of amiodarone: The stabilizing effect of phosphate anions
2001, Colloids and Surfaces B: BiointerfacesAmiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland, and lung
2000, American Journal of the Medical Sciences
- ☆
Supported by grants from the Medical Research Service of the Veterans Administration and the American Heart Association, the Greater Los Angeles Affiliate; and by grant 23970 from the National Heart, Lung and Blood Institute.
Copyright © 1983 Published by Mosby, Inc.